Procalcitonin level and its predictive effect on mortality in crimean-congo hemorrhagic fever patients

Japanese Journal of Infectious Diseases

Volumn 68, Issue 6, 2015, Pages 511-513

  Gul, Serdar ^a   Ozturk, Dogan Baris ^b   Kisa, Ucler ^a   Kacmaz, Birgul ^a   Yesilyurt, Murat ^c  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b Ulucanlar Education and Research Eye Hospital   (Turkey)

^c Tekirdag State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; HEMOGLOBIN; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CRIMEAN CONGO HEMORRHAGIC FEVER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PROGNOSIS; THROMBOCYTE COUNT; ADOLESCENT; BLOOD; DIAGNOSTIC TEST; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; SURVIVAL ANALYSIS; TURKEY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS; SURVIVAL ANALYSIS; TURKEY; YOUNG ADULT;

EID: 84947758005     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.JJID.2014.485     Document Type: Article

References (20)

1. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-14.
2. Yilmaz GR, Buzgan T, Irmak H, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis. 2009;13:380-6.
3. Whitehouse CA. Crimean-Congo haemorrhagic fever. Antiviral Res. 2004;64:145-60.
4. Guven H, Altintop L, Baydin A, et al. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med. 2002;20:202-6.
5. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C reactive protein levels as markers of bacterial infection: a system atic review and meta-analysis. Clin Infect Dis. 2004;39:206-17.
6. Akinci E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2013;13: 429-37.
7. Weber F, Mirazimi A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 2008;19:395-404.
8. Ergonul O, Tuncbilek S, Baykam N, et al. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factoralpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006;193:941-4.
9. Papa A, Bino S, Velo E, et al. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol. 2006;36:272-6.
10. Ozturk B, Kuscu F, Tutuncu E, et al. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with CrimeanCongo hemorrhagic fever. J Clin Virol. 2010;47:115-9.
11. Swanepoel R, Gill DE, Shepherd AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11: S794-800.
12. Bakir M, Ugurlu M, Dokuzoguz B, et al. Turkish CCHF Study Group. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol. 2005;54:385-9.
13. Ergonul O, Celikbas A, Baykam N, et al. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006;12: 551-4.
14. Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008;12:374-9.
15. Ozturk B, Tutuncu E, Kuscu F, et al. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Int J Infect Dis. 2012;16:e89-93.
16. Jereb M, Lunaeek NK, Kotar T, et al. Procalcitonin in hantavirus infections. Scand J Clin Lab Invest. 2011;71:287-91.
17. Povoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002;28:235-43.
18. Sari I, Bakir S, Engin A, et al. Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever. Bosn J Basic Med Sci. 2013;13:21-6.
19. Foushee JA, Hope NH, Grace EE. Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays. J Antimicrob Chemother. 2012;67:2560-9.
20. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605-8.